In the end, the premium paid will depend on how much of a fight they want to put up. Hostile takeovers are atypical in Japanese culture, so I wouldn't expect they will try and pounce unless they're confident it would go through. I think most shareholders would dismiss a takeover lower than $200M (~$1/share), since that wasn't successful over 4 years and the company is further advanced now. Perhaps not as advanced as they should be, but I think the below shows the value-added:
Indication Status end-2019 Status end-2023 1 Knee Osteoarthritis Ready P2 Completed P3, Results due early 2026 2 GvHD Plan P2, partnered Recruiting P2, no partner 3 DFU pre-clinical Recruiting P1, Results mid-2024 4 Renal Transplant pre-clinical Plan P1, Results early 2025 5 CLI Ready P2 Ready P2; no plans to commence trial
And there has also some more significant research comparing and contrasting MSC heterogeneity, with Cymerus MSCs "exhibit[ing] less batch-batch heterogeneity than tissue-derived MSCs, furthermore they also exhibit significantly less intrapopulation variation."
Since 2019, have we also seen, twice, the FDA raise serious questions regarding the heterogeneity of a proposed commercial MSC product and subsequently requested they re-do clinical trials.
The share price collapse of Cynata since 2019 has been an important lesson in capital allocation. It could get worse over the next 12 months, too, if recruiting rates continue to be frustratingly slow and the board fail to learn their lesson when figuring out how to bridge capital for the next 3 years. Regardless, I think clinically as much as possible is being done to demonstrate the underlying value of the platform. Hopefully as this is released, bigger pharma companies look at iMSCs as less of a science experiment and more of a viable commercial treatment with huge market opportunities.
- Forums
- ASX - By Stock
- CYP
- FUJIFILM CDI Facility
FUJIFILM CDI Facility, page-4
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $37.01M |
Open | High | Low | Value | Volume |
20.5¢ | 20.5¢ | 20.5¢ | $334 | 1.628K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 15518 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 44372 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 15518 | 0.195 |
3 | 121013 | 0.190 |
3 | 15055 | 0.180 |
2 | 5997 | 0.175 |
1 | 50000 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 44372 | 1 |
0.210 | 60000 | 1 |
0.220 | 1875 | 1 |
0.240 | 10000 | 1 |
0.250 | 2225 | 1 |
Last trade - 14.54pm 02/09/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |